Koyfin Home > Directory > Health Care > Rhythm Pharmaceuticals Inc > EBITDA

Rhythm Pharmaceuticals Inc EBITDA Chart (RYTM)

Rhythm Pharmaceuticals Inc annual/quarterly EBITDA from 2016 to 2018. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Rhythm Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $-27m a 37.36% decrease of -10m year over year
  • Rhythm Pharmaceuticals Inc EBITDA for the last 12 months ending December 12, 2018 was $-78m a 45.22% decrease of -35m year over year
  • Rhythm Pharmaceuticals Inc Annual EBITDA for 2018 was $-78m a 58.79% decrease of -46m from 2017
  • Rhythm Pharmaceuticals Inc Annual EBITDA for 2017 was $-32m a 19.97% decrease of -6m from 2016
  • Rhythm Pharmaceuticals Inc Annual EBITDA for 2016 was $-26m
Other Income Statement Metrics:
  • Rhythm Pharmaceuticals Inc Net Income for the quarter ending September 09, 2018 was $-18m a 40.46% decrease of -7m year over year
View Chart On Koyfin

Quarterly RYTM EBITDA Data

12/2018$-27m
09/2018$-19m
06/2018$-15m
03/2018$-17m
12/2017$-11m
09/2017$-8m
06/2017$-7m
03/2017$-6m
12/2016$-8m

Annual RYTM EBITDA Data

2018$-78m
2017$-32m
2016$-26m